Respir J 2005; 26: 720-735.
10. BÁRBARA C, RAMOS F, ALMEIDA M, MARQUES GOMES MJ, SEGORBE LUÍS A. Programa Nacional de Prevenção e Controlo da Doença Pulmonar Obstructiva Crónica. Direcção Geral da Saúde; circular normativa nº04/DGCG de 17 Março de 2005.
11. BASSETT D, CURETON A, AINSWORTH B. Measurement of daily walking distance- questionnaire versus pedometer. Med Sci Sports Exerc 2000; 32 (5): 1018-1023.
12. BAUERLE O, CHRUSCH C, YOUNES M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998; 157: 57-68.
13. BELZA B, STEELE B, HUNZIKER J, LAKSHIMINARYAN S, HOLT L, BUCHNER D. Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res 2001; 50 (4): 195-202. 14. BESTALL J, PAUL E, GARROD R, GARNHAM R, JONES P, WEDZICHA J. Usefulness of the
Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
16. BLOK B, GREEF M, HACKEN N, SPRENGER S, POSTEMA K, WEMPE J. The effects of a lifestyle physical activity counselling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Education and Counseling 2006; 61: 48-55.
17. BOHANNON R. Number of pedometer-assessed steps taken per day by adults: a descriptive meta-analysis. Physical Therapy J 2007; 87: 1642-1650.
18. BORG G. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381. 19. BOWEN J, VOTTO J, THRALL R, HAGGERTY M, STOCKDALE-WOOLLEY R,
BANDYOPADHYAY T, ZUWALLACK R. Functional status and survival following pulmonary rehabilitation. Chest 2000; 118: 697-703.
20. BRANCO M, NOGUEIRA P, NUNES B. Actividade física da população portuguesa. ONSA 1999: 1-4.
21. BRAVATA D, SMITH-SPANGLER C, SUNDARAM V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007; 298 (19): 2296-2304. 22. BRESLIN E, VAN DER SCHANS C, BREUKINK S, MEEK P, MERCER K, VOLZ W, LOUIE S.
Perception of fatigue and quality of life in patients with COPD. Chest 1998; 114: 958-964. 23. BROWN C, WISE R. Field tests of exercise in COPD: the six-minute walk test and the shuttle
walk test. COPD: Journal of Chronic Obstructive Pulmonary Disease 2007; 4: 217-223.
24. CAMÕES M, LOPES C. Factores associados à actividade física na população portuguesa. Rev Saúde Pública 2008; 42 (2): 208-216.
25. CARLSON D, RIES A, KAPLAN R. Exercise tolerance in patients with COPD. Chest 1991; 100: 307-311.
26. CARMO M, BÁRBARA C, NEVES P, BRANCO J, CANTEIRO M, RENDAS A. Avaliação da dispneia e padrões ventilatórios num grupo de doentes com limitação crónica do débito aéreo candidatos a um programa de reabilitação. Rev Port Pneumol 1995; I (2): 119-127.
27. CARR S, GOLDSTEIN R, BROOKS D. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 2007; 132: 127-134.
28. CARTER R, HOLIDAY D, NWASURUBA C, STOCKS J, GROTHUES C, TIEP B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003; 123: 1408-1415. 29. CASABURI R, PORSZASZ J, BURNS M, CARITHERS E, CHANG R, COOPER C. Physiologic
benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-1551.
30. CASABURI R. Activity monitoring in assessing activities of daily living. COPD: Journal of Chronic Obstructive Pulmonary Disease 2007; 4: 251-255.
L, CELLI B. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007; 29: 535-540
32. CASAS A, VILARO J, RABINOVICH R, MAYER A, BARBERÀ J, RODRIGUEZ-ROISIN R, ROCA J. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128: 55-61.
33. CELLI B, COTE C, MARIN J, CASANOVA C, OCA M, MENDEZ R, PLATA V, CABRAL H. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004; 350 (10): 1005-1012.
34. CHAN C, RYAN D, TUDOR-LOCKE C. Health benefits of a pedometer-based physical activity intervention in sedentary workers. Preventive Medicine 2004; 39: 1215-1222.
35. CHAVANNES N, VOLLENBERG J, SCHAYCK C, WOUTERS E. Effects of physical activity in mild to moderate COPD: a systematic review. British J General Practice 2002; 52: 574-578. 36. CORONADO M, JANSSENS J, MURALT B, TERRIER P, SCHUTZ Y, FITTING J. Walking
acitvity measured by accelerometry during respiratory rehabilitation. J Cardiopulm Rehabil 2003; 23 (5):357-364.
37. COTE C, PINTO-PLATA V, KASPRZYK K, DORDELLY L, CELLI B. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007; 132: 1778-1785.
38. CRISAFULLI E, COSTI S, DEBLASIO F, BISCIONE G, AMERICI F, PENZA S, EUTRÓPIO E, PASQUA F, FABBRI L, CLINI E. Effects of a walking aid in COPD patients receiving oxygen therapy. Chest 2007; 131: 1068-1074.
39. CYARTO E, MYERS A, TUDOR-LOCKE C. Pedometer accuracy in nursing home and community-dwelling older adults. Med Sci Sports Exerc 2004; 36 (2): 205-209.
40. DONALDSON G, WILKINSON T, HURST J, PERERA W, WEDZICHA J. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171 (5): 446-452.
41. D’URZO A, MATEIKA J, BRADLEY D, LI D, CONTRERAS M, GOLDSTEIN R. Correlates of arterial oxygenation during exercise in severe chronic obstructive pulmonary disease. Chest 1989; 95: 13-17.
42. EISER N, WEST C, EVANS S, JEFFERS A, QUIRK F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 1997; 10: 1581-1584.
43. EISNER M, IRIBARREN C, YELIN E, SIDNEY S, KATZ P, ACKERSON L, LATHON P, TOLSTYKH I, OMACHI T, BYL N, BLANC P. Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease. Am J Epidemiol 2008; 167: 1090-1101. 44. ENGSTROM C, PERSSON L, LARSSON S, RYDEN A, SULLIVAN M. Functional status and
smoking: a descriptive and comparative study. Thorax 1996; 51: 825-830.
45. FABIÃO C, BARBOSA A, FLEMING M, SILVA C. Rastreio da perturbação de somatização nos cuidados primários de saúde: resultados de um estudo piloto. Acta Med Port 2008; 21: 319-328. 46. FREITAS C, PEREIRA C, VIEGAS C. Inspiratory capacity, exercise limitation, markers of
severity, and prognostic factors in chronic obstructive pulmonary disease. J Bras Pneumol 2007; 33 (4): 389-396.
47. FUNK G, KIRCHHEINER K, BURGHUBER O, HARTL S. BODE index versus GOLD classification for explaning anxious and depressive symptoms in patients with COPD – a cross- sectional study. Respiratory Research 2009; 10: 1-8.
48. GALLEGO M, SAMANIEGO J, ALONSO J, SÁNCHEZ A, CARRIZO S, MARÍN J. Dyspnea in COPD: relation to the MRC scale with dyspnea induced by walking and cardiopulmonary stress testing. Arch Bronconeumol 2002; 38 (3): 112-6.
49. GARCIA-AYMERICH J, FELEZ M, ESCARRABILL J, MARRADES R, MORERA J, ELOSUA R, ANTO J. Physical activity and its determinants in severe chronic obstructive pulmonary disease. Med Sci Sports Exerc 2004; 36 (10): 1667-1673.
50. GARCIA-AYMERICH J, LANGE P, BENET M, SCHNOHR P, ANTO JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778.
51. GARCIA-AYMERICH J, LANGE P, BENET M, SCHNOHR P, ANTO JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007; 175: 458-463.
52. GARROD R, BESTALL J, PAUL E, WEDZICHA J, JONES P. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 2000; 94: 589-596.
53. GARROD R, PAUL EA, WEDZICHA JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000; 55: 539-543.
54. GARROD R, PAUL EA, WEDZICHA JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL). Respir Med 2002; 96: 725-730.
55. GARROD R, MARSHALL J, JONES F. Self efficacy measurement and goal attainment after pulmonary rehabilitation. International Journal of COPD 2008; 3 (4): 791-796.
56. GROSS N. Chronic obstructive pulmonary disease outcoume measurements. What’s important? What’s useful? Proc Am Thorac Soc 2005; 2: 267-271.
57. HADELI KO, SIEGEL EM, SHERRILL DL, BECK KC, ENRIGHT PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 2001; 120: 88-92
58. HAJIRO T, NISHIMURA K, TSUKINO M, IKEDA A, KOYAMA H, IZUMI T. Analysis of Clinical Methods Used to Evaluate Dyspnea in Patients with Chronic Obstructive Lung Disease. Am J Respir Crit Care Med 1998; 158: 1185-1189.
59. HALLSTROM C, MCCLURE N. Ansiedade e Depressão – perguntas e respostas. 1ª Edição, Climepsi Editores, 2000.
60. HARIK-KHAN R, FLEG J, WISE R. Body mass index and the risk of COPD. Chest 2002; 121: 370-376.
61. HASKELL W, LEE I, PATE R, POWELL K, BLAIR S, FRANKLIN B, MACERA C, HEATH G, THOMPSON P, BAUMAN A. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39 (8): 1423-1434.
62. HERNANDES N, TEIXEIRA D, PROBST V, BRUNETTO A, RAMOS E, PITTA F. Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol 2009; 35 (10): 949-956.
63. HOLIDAY D, NWASURUBA C, STOCKS J, GROTHUES C, TIEP B. 6-Minute Walk Work for Assessment of Functional Capacity in Patients with COPD. Chest 2003; 123; 1408-1415. 64. ISCHAKI E, PAPATHEODOROU G, GAKI E, PAPA I, KOULOURIS N, LOUKIDES S. Body
mass and fat-free mass indices in COPD. Chest 2007; 132: 164-169.
65. KAFI S, DEBOECK G. Le test de marche de six minutes en rehabilitation respiratoire. Rev Mal Respir 2005; 22: 7S54-7S58.
66. KARAPOLAT H, EYIGOR S, ATASEVER A, ZOGHI M, NALBANTGIL S, DURMAZ B. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure. Chin Med J 2008; 121 (7): 592-596.
67. KATCH, F et al. Nutrição, Exercício e Saúde. 4ª Edição. Rio de Janeiro: Editora Medsi, 1996. 68. KATULA J, REJESKI W, WICKLEY K, BERRY M. Perceived difficulty, importance, and
satisfaction with physical function in COPD patients. Health and Quality of Life Outcomes 2004; 2: 18-23.
69. KNOWER MT, DUNAGAN DP, ADAIR NE, CHIN R. Baseline Oxygen Saturation Predicts Exercise Desaturation Below Prescription Threshold in Patients with Chronic Obstructive Pulmonary Disease. Arch Intern Med 2001; 161: 732-736.
70. KNOWER WC, BARRETT-CONNOR E, FOWLER SE, HAMMAN RF, LACHIN JM, WALKER EA, NATHAN DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
modified pulmonary functional status and dyspnea questionnaire and the Medical Research Council scale for use in brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008; 34 (12): 1008-1018.
72. LE MASURIER G, LEE S, TUDOR-LOCKE C. Motion sensor accuracy under controlled and free-living conditions. Med Sci Sports Exerc 2004; 36 (5): 905-910.
73. LIN Y, XU W, LIANG L, PANG B, NIE X, ZHANG J, WANG H, LIU Y, et al. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Chin Med J 2009; 122 (24): 2939-2944.
74. LIZAK MK, SINGH S, LUBINA S, ZEMBALA M. Female and male chronic obstructive pulmonary disease patients with severe dyspnea do not profit less from pulmonary rehabilitation. Pol Arch Med Wewn 2008; 118: 413-418.
75. LORENZI C, CILIONI C, RIZZARDI R, FURINO V, BELLANTONE T, LUGLI D, CLINI E.